CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -99.7% | 1 | -99.7% | 0.00% | – |
| Q4 2022 | $311 | -96.9% | 359 | -95.6% | 0.00% | – |
| Q3 2022 | $10,000 | +42.9% | 8,091 | -0.8% | 0.00% | – |
| Q2 2022 | $7,000 | -74.1% | 8,155 | -7.7% | 0.00% | – |
| Q1 2022 | $27,000 | 0.0% | 8,836 | +66.7% | 0.00% | – |
| Q4 2021 | $27,000 | +17.4% | 5,299 | +342.7% | 0.00% | – |
| Q2 2021 | $23,000 | – | 1,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 597,678 | $771,000 | 0.24% |
| Kynam Capital Management, LP | 739,649 | $954,000 | 0.20% |
| RA Capital Management | 6,991,003 | $9,018,000 | 0.19% |
| Octagon Capital Advisors LP | 450,000 | $581,000 | 0.10% |
| Ikarian Capital, LLC | 219,501 | $283,000 | 0.06% |
| UBS OCONNOR LLC | 613,931 | $792,000,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,277,519 | $1,648,000 | 0.00% |
| ROCKY MOUNTAIN ADVISERS, LLC | 1,200 | $2,000 | 0.00% |
| CSS LLC/IL | 38,721 | $50,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $35,000 | 0.00% |